Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Change in Accured Expenses (2020 - 2025)

TScan Therapeutics (TCRX) has disclosed Change in Accured Expenses for 6 consecutive years, with -$3.4 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 192.16% to -$3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.2 million through Dec 2025, down 259.44% year-over-year, with the annual reading at -$7.2 million for FY2025, 259.44% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$3.4 million at TScan Therapeutics, down from -$1.1 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.7 million in Q4 2024, with the low at -$5.4 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $256250.0, with a median of $760000.0 recorded in 2023.
  • The sharpest move saw Change in Accured Expenses soared 199.82% in 2021, then tumbled 317.37% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $1.8 million in 2021, then fell by 28.37% to $1.3 million in 2022, then fell by 0.91% to $1.3 million in 2023, then soared by 179.33% to $3.7 million in 2024, then crashed by 192.16% to -$3.4 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$3.4 million, -$1.1 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.